Brisa Bond - Gel Bonding Agent

SECTION 2: Hazards identification

This product is classified as a HAZARDOUS SUBSTANCE and as DANGEROUS GOODS according to the classification criteria of NOHSC:1088 (2004) and ADG Code (Australia). Routes of Entry: Inhalation: YES Absorption: YES Ingestion: YES Effects of Exposure: INGESTION: Gastrointestinal irritation and central nervous system depression. EYES: Mild to moderate irritation. SKIN: Irritant and potential skin sensitizer. Prolonged or repeated skin contact may cause contact dermatitis (localized redness or rash). INHALATION: Central nervous system depressant. Irritating to the upper respiratory tract. 2.4 Symptoms of Overexposure: INGESTION: Nausea, vomiting, and diarrhea. EYES: Mild irritation, redness, and watering. SKIN: Contact dermatitis, characterized by localized red or puffy dry skin and itching. INHALATION: Mouth, nose, and throat irritation, dizziness, nausea, light-headedness, drunkenness, and loss of coordination. 2.5

Potential Acute Health Effects

INGESTION: Gastrointestinal irritation and central nervous system depression. EYES: Mild to moderate irritation. SKIN: Irritant and potential skin sensitizer. Prolonged or repeated skin contact may cause contact dermatitis (localized redness or rash). INHALATION: Central nervous system depressant. Irritating to the upper respiratory tract. 2.6

Potential chronic health

INGESTION: None reported by the manufacturer. EYES: None reported by the manufacturer. SKIN: None reported by the manufacturer. INHALATION: None reported by the manufacturer. 2.7 Target Organs: Skin, eyes and respiratory system. NA = Not Available; ND = Not Determined; NE = Not Established; NF = Not Found; C = Ceiling Limit; See Section 16 for Additional Definitions of Terms Used. Note: All WHMIS required information is included. It is located in appropriate sections based on the ANSI Z400.1-2004 format.